Welcome to our dedicated page for Dupont De Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DuPont de Nemours, Inc. filings document the regulatory disclosures of a Delaware specialty materials company with common stock listed on the New York Stock Exchange under DD. Its 8-K reports cover operating and financial results, Regulation FD disclosures, material events, board composition changes, corporate-governance matters and capital-structure disclosures.
DuPont proxy materials describe annual stockholder voting matters, director elections, governance practices, executive compensation and proposals affecting the company’s certificate of incorporation and common stock. Recent filings also document separation-related matters, including disclosures connected with the completed Qnity Electronics spin-off, as well as agreements and percentage calculations tied to the post-separation corporate structure.
DuPont de Nemours, Inc. director Eleuthere I. du Pont reported an acquisition of company common stock. On May 21, 2026, he received 4,030 shares of common stock in a grant or other award at a stated price of $0.00 per share. A footnote explains that this amount includes shares acquired through dividend reinvestment. Following this transaction, his directly held stake increased to 42,371.4961 shares of DuPont common stock.
DuPont de Nemours, Inc. director Alexander M. Cutler reported receiving 4,030 shares of Common Stock on May 21, 2026. The shares were recorded as a grant or award at a reported price of $0.00 per share and include shares acquired through dividend reinvestment.
After this acquisition, Cutler’s directly held stake increased to 80,761.773 shares of DuPont common stock, reflecting a routine, compensation-related and dividend-linked increase in his equity position rather than an open-market purchase or sale.
DuPont de Nemours, Inc. director Ruby R. Chandy reported an acquisition of company Common Stock through a compensation-related grant. She received 4,030 shares at no stated price, including shares from dividend reinvestment, increasing her direct holdings to 25,444.3791 shares after the transaction.
DuPont de Nemours, Inc. director Amy G. Brady reported receiving a grant or award of 4,030 shares of Common Stock on May 21, 2026. The shares were acquired at no stated price per share, and the total direct holdings after this acquisition are 23,780.6788 shares. A footnote states that the total includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. reported results from its 2026 annual meeting and detailed a reverse stock split. Stockholders elected 10 directors, approved executive compensation, ratified PricewaterhouseCoopers LLP as auditor for 2026, and authorized a reverse stock split and corresponding reduction in authorized shares.
The Board has set a 1-for-3 reverse stock split, expected to become effective at 12:01 a.m. Eastern Time on June 24, 2026, after which DuPont shares will trade on a split-adjusted basis on the NYSE under the existing ticker DD. Authorized common shares will be reduced from 1,666,666,667 to 555,555,556, and outstanding shares would have been reduced proportionately from approximately 405,058,202 to 135,019,401 if applied as of May 22, 2026, with cash paid in lieu of fractional shares.
DuPont also reaffirmed its second quarter and full-year 2026 financial guidance and provided split-adjusted adjusted earnings per share targets. For 2Q 2026, adjusted EPS guidance is approximately $1.75 (previously ~$0.59), and for full-year 2026, adjusted EPS guidance is $7.02–$7.16 (previously $2.35–$2.40), based on a projected weighted average diluted share count of about 137 million shares.
DuPont de Nemours, Inc. director Edward D. Breen reported a routine tax-withholding transaction related to equity compensation. On May 4, 2026, 11,538.1584 shares of Common Stock were disposed of to cover taxes on lapsed RSUs and associated dividend equivalent units. This was not an open-market sale. After this withholding, Breen directly holds 273,977.876 shares of DuPont common stock, including shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. SVP & CFO Antonella B. Franzen reported a routine tax-withholding share disposition related to vesting equity awards. On this event, 245.8361 shares of common stock were withheld at $45.54 per share to cover taxes on lapsed RSUs and associated dividend equivalent units, rather than sold on the open market. After this withholding, she directly holds 70,366.7801 shares of DuPont common stock, including shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. senior vice president and general counsel Erik T. Hoover reported a routine tax-related share disposition. On May 4, 2026, 1,525.6839 shares of common stock were withheld at $45.5400 per share to cover taxes on lapsed RSUs and associated dividend equivalent units. Following this withholding and including shares acquired through dividend reinvestment, Hoover directly holds 115,971.9470 shares of DuPont common stock.
DuPont de Nemours, Inc. CEO Lori Koch reported a tax-withholding disposition of 3,048.3678 shares of Common Stock at $45.54 per share. The shares were withheld on May 4, 2026 to cover taxes on lapsed RSUs and related dividend equivalent units, rather than sold in the open market.
After this withholding, Koch directly holds 349,844.5631 shares of DuPont Common Stock, which includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. Senior Vice President & CHRO Christopher Raia reported a tax-related share disposition. On lapsed RSUs and related dividend equivalent units, 1,270.3893 common shares were withheld at $45.54 per share to cover tax obligations, rather than sold on the open market.
After this withholding, Raia directly holds 85,911.2563 DuPont common shares, which includes shares acquired through dividend reinvestment.